Half-year Report

Summary by AI BETAClose X

International Biotechnology Trust PLC reported a strong first half for the year ending 28 February 2026, with a share price total return of 39%, outperforming its reference index by 9.5%. The company paid an interim dividend of 15.64 pence per share, resulting in a dividend yield of 3.2% as of the reporting date. The portfolio managers continue to focus on late-stage, high-growth biotechnology companies, which have shown resilience and attracted strategic interest from larger pharmaceutical firms, evidenced by five portfolio company acquisitions during the period. The net asset value per share increased by 35.7%, and the discount to NAV narrowed from 8.9% to 6.7%.

Disclaimer*

UK 100

Latest directors dealings